TULA Skincare Go Away Acne Spot Treatment

Product NDC: 72296-040
Requested package NDC: 72296-040-15
11-digit product format: 722960040
Labeler code: 72296
Product ID: 72296-040_a52ed291-5333-41fc-9def-3a06490b616d
Type: HUMAN OTC DRUG
Nonproprietary name: TULA Skincare Go Away Acne Spot Treatment
Dosage form: LIQUID
Route: TOPICAL
Labeler: Tula Life LLC
Application: part333D
Marketing category: OTC MONOGRAPH FINAL
Marketing start: 2021-12-24
Marketing end: 0000-00-00
Substance: BENZOYL PEROXIDE
Active strength: 5 g/100g
NDC exclude flag: No
Listing certified through: 2023-12-31
Current FDA listing: Historical FDA.report record

NDC auxiliary status#

These records are reproduced from FDA’s unfinished, excluded, and compounder listings. They describe what appeared in the source files; a missing record does not establish a regulatory status. View all current auxiliary records, including entries without an NDC. · View the auxiliary file history.

Current NDC status page 1 of 1 · 1 matching rows.

Dataset, Scope, Product NDC table
Dataset	Scope	Product NDC	Package NDC	Code	Status	Reporting period	Source date
excluded package	package	72296-040	72296-040-15	I	Inactivated by FDA		2026-10-05

Observed NDC auxiliary status history#

This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.

Historic NDC status page 1 of 1 · 15 matching rows.

View current auxiliary records. · View the auxiliary file history.

Captured / source date, Snapshot, Source SHA-256 table
Captured / source date	Snapshot	Source SHA-256
2025-12-14 17:58 UTC · source 2025-12-05	`d630ba8d3edf…`	`732f749b63fb…`
2025-08-27 00:01 UTC · source 2025-08-26	`f5e01cc5f278…`	`a2eaf40c39c3…`
2025-04-01 02:39 UTC · source 2025-03-31	`2ef7874e63bc…`	`57b86245f4fa…`
2025-03-28 20:22 UTC · source 2025-03-28	`a1b67e2a42f9…`	`c4cf2c586c0d…`
2025-03-22 03:12 UTC · source 2025-03-21	`cfe11265f3b6…`	`090c488252e2…`
2025-03-10 12:48 UTC · source 2025-03-10	`cdf11ea48f46…`	`ba0047e9e063…`
2025-02-02 03:52 UTC · source 2025-01-31	`302b2466d912…`	`e7b80fea0513…`
2025-01-20 13:05 UTC · source 2025-01-20	`ed331223b511…`	`672a5bd82f5f…`
2025-01-11 03:41 UTC · source 2025-01-10	`0efc9e666f02…`	`f202fb6c5f17…`
2024-11-09 02:27 UTC · source 2024-11-08	`ad56d346431e…`	`cc804d4bbf1e…`
2024-10-04 04:10 UTC · source 2024-10-03	`367a005e9d99…`	`383a685ebd0f…`
2024-07-10 04:00 UTC · source 2024-07-09	`557ba5c1ecfa…`	`9c80585c8c6e…`
2024-05-28 21:12 UTC · source 2024-05-28	`8af77b9d5b6f…`	`d9bbb34c5368…`
2024-05-15 03:39 UTC · source 2024-05-14	`834df4deac94…`	`adcc014656a3…`
2024-03-11 06:39 UTC · source 2024-03-08	`1332a3947898…`	`d4bfe170f9cd…`

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

DailyMed Product Concepts#

Product concept, Relation, Version table
Product concept	Relation	Version	Effective
a46239a7-5963-4008-8cbb-6b9000f497eb	Product name	1	20250721
b382b4e1-6b48-45f6-bffc-e61b00b0ce19	Product name	3	20250317
d9d61457-6a5a-41fc-b418-e5479a2904b7	Product name	2	20230303
32012d5c-25ac-49c7-9d4c-1313177fff7c	Product name	1	20230112
13e7e7e3-e885-4c79-af6d-dad1aedbb06e	Product name	1	20220128
4a7d44fe-774d-404b-aad0-8a90fe78375a	Product name	4	20211025
f52be47f-7aa7-46c0-b1fa-50c18dd50206	Product name	1	20201029
3f45980c-c196-47e5-0e5e-48b7c57327c5	Product name	5	20200428
6c6fc281-9445-2e9e-1c29-a09ddbc4299c	Product name	2	20200213
d12e2d7c-bd6b-45d4-94f9-6df8e1b8b27b	Product name	3	20200203
ee5c6de5-d9cd-454f-b250-7b19e5cf2992	Product name	4	20190619
444b3e50-f226-46ef-bfca-2e7035d140cd	Product name	1	20190611
7cda52fc-125f-421c-8fea-bc1974370c49	Product name	2	20180703
ad75fcfd-a339-42a1-9c60-43ba2c654cfa	Product name	1	20170810
d5e51f11-ad28-caa4-4b49-4143974782ad	Product name	1	20150831
2a856070-cbe7-4f85-be0f-09885ff91196	Product name	1	20150806
597b1cfd-7b31-5048-62be-ca5cd740da2f	Product name	1	20140508
ec2149b3-5c6d-5344-f757-c86411073075	Product name	1	20140508

FDA-Initiated Inactive NDC Indexing#

NDC, Effective, Action table
NDC	Effective	Action	Document	Indexing SPL	Related label
72296-040-15	2023-07-28	C162847	48780-1	c7ccaba7-1da3-fd44-e053-dadaa90aa01b	DRUG FACTS
72296-040-15	2021-12-24	C162847	48780-1	c7ccaba7-1da3-fd44-e053-dadaa90aa01b	DRUG FACTS
72296-040-15	2021-07-23	C162847	48780-1	c7ccaba7-1da3-fd44-e053-dadaa90aa01b	DRUG FACTS

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDC	Product	Description	Form	Quantity	Strength	SPL version
72296-040-15	TULA Skincare Go Away Acne Spot Treatment	1 in 1 CARTON	LIQUID	1		5
72296-040-15	TULA Skincare Go Away Acne Spot Treatment	15 g in 1 TUBE	LIQUID	15		5

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDC	Dashboard title	SPL version	Validation	Dashboard ZIP
72296-040	TULA SKINCARE GO AWAY ACNE SPOT TREATMENT LIQUID [TULA LIFE LLC]	5	Legacy NDC, 2 package rows	20230101_60eeddcc-2a25-4f9e-87ba-3b1182397766.zip

UNII, Preferred term, Registry number table
UNII	Preferred term	Registry number	Matched term
W9WZN9A0GM	BENZOYL PEROXIDE	94-36-0	BENZOYL PEROXIDE

Packages#

Package NDC, 11-digit format, Description table
Package NDC	11-digit format	Description	Units	Marketing start	Marketing end	Sample	Exclude flag	Status
72296-040-15	72296004015	1 TUBE in 1 CARTON (72296-040-15) > 15 g in 1 TUBE	1 tube	2021-12-24	0000-00-00	No	No	Current